Home > Blog Tag

Blog Posts by Tag: Pathology

Laboratory Economics' Anatomic Pathology & Clinical Lab Survey

Attention pathology groups! Laboratory Economics, an independent market research firm focused on the business of pathology and laboratory medicine, is conducting a survey to gain insight on current business trends among anatomic pathology groups and clinical labs. Please take a few moments to fill out this survey and in return for your participation, you will receive a full summary of the survey...


Digital Pathology Primary Diagnosis is Approved – Is Your Lab Ready for the Future?

Earlier this month, there was an exciting announcement that Leica received their FDA 510(k) clearance to market a digital pathology whole slide imaging system for primary diagnosis. This comes on the heels of Philips’ groundbreaking announcement of FDA clearance in late 2017, which was the first device ever cleared for primary diagnosis. These advancements are initiating significant momentum in...


Hidden Landmines in Revenue Cycle Management: Industry Challenges, Patient Engagement, and Denial Trends (Part 1)

This is the first post of a three-part blog series focused on key areas of business performance management for pathology practices, diagnostic laboratories, and molecular diagnostic providers. The other blog posts in this series can be found here:  Part 2 and Part 3 A number of trends in payor behaviors and reimbursement go unnoticed due to...


Hidden Landmines in RCM: Understanding Trends that Impact Financial Performance of Laboratories and Pathology Practices

With layers of complexity in revenue cycle management, it’s pertinent laboratories and pathology practices understand the challenges that may unknowingly be impacting revenue. Industry trends consistently change how we approach the nuances of the RCM process. How trends in top denials shifted in the last several year's impacts how we edit on the front-end and appeal on the back-end. Routinely...


Clinical Lab 2.0: Data Driven Strategies that Position Labs to Compete in the Changing Healthcare Landscape

Summary: Clinical Lab 2.0 facilitates thought leadership efforts to identify opportunities and threats that provide insight into laboratory operations and identify value streams to drive efficiency for the laboratory, health systems and positive outcomes for patients.Clinical Lab 2.0 is all about the future of capturing new customers, partners and markets.  For laboratories to compete, new...


What do the CMS Medicare Physician Fee Schedule Changes Mean for Pathology Labs?

Right now, clinical laboratories and pathology practices are faced with the continuance of PAMA cuts and budgeting based on the proposed changes to the Medicare Fee Physician Fee Schedule. Both scenarios reinforce the need to be more aware of the financial implications of these updates as well as the general underlying cost of running laboratories.While the mission of providing quality health...